Treatment of proximal deep-vein thrombosis with the oral direct factor Xa inhibitor rivaroxaban (BAY 59-7939): the ODIXa-DVT study - Agnelli, G; Gallus, A; Goldhaber, SZ (Circulation, 2007)
et al.